CNBX Pharmaceuticals Inc. (CNBX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 08-31. Amounts in USD.

Revenue Quarterly

0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q3 '26: 0 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Gross Profit Quarterly

0 15K 30K 45K Q2 '18: 1.9K Q1 '19: 3.3K Q2 '23: 0 Q2 '24: 34.4K Q2 '25: 0 Q3 '25: 0 Q2 '26: 0 Q3 '26: 0 Q2 '18 Q1 '19 Q2 '23 Q2 '24 Q2 '25 Q3 '25 Q2 '26 Q3 '26

Operating Income Quarterly

-180K -120K -60K 0 60K 120K 180K Q4 '24: -52.5K Q1 '25: -36.8K Q2 '25: -64.7K Q3 '25: -40.4K Q4 '25: -129.7K Q1 '26: -64K Q2 '26: -73K Q3 '26: -162.8K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Net Income Quarterly

-180K -120K -60K 0 60K 120K 180K Q4 '24: -60.6K Q1 '25: -34.4K Q2 '25: -69.8K Q3 '25: -59.7K Q4 '25: -150.1K Q1 '26: -113.7K Q2 '26: -44.1K Q3 '26: -154.2K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Cost of Revenue Quarterly

0 2.5K 5K 7.5K Q3 '17: 0 Q2 '18: 0 Q2 '23: 0 Q2 '24: 6.2K Q2 '25: 0 Q3 '25: 0 Q2 '26: 0 Q3 '26: 0 Q3 '17 Q2 '18 Q2 '23 Q2 '24 Q2 '25 Q3 '25 Q2 '26 Q3 '26

Operating Cash Flow Quarterly

-60K -40K -20K 0 20K 40K 60K Q4 '24: -48.2K Q1 '25: -39.1K Q2 '25: -51.7K Q3 '25: -52K Q4 '25: -28.5K Q1 '26: -47.4K Q2 '26: -30.5K Q3 '26: -47.7K Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

Free Cash Flow Quarterly

-120K -80K -40K 0 40K 80K 120K Q1 '15: -113.3K Q2 '15: -55.2K Q3 '15: 13.7K Q1 '16: -35.7K Q2 '16: -26.2K Q3 '16: 11.1K Q1 '15 Q2 '15 Q3 '15 Q1 '16 Q2 '16 Q3 '16

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q2 '24: 31M Q3 '24: 31.1M Q1 '25: 31.1M Q2 '25: 32.1M Q3 '25: 42.6M Q1 '26: 732.9M Q2 '26: 931M Q3 '26: 1.3B Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.02 -0.01 -0.01 0.00 0.01 0.01 0.02 Q4 '24: -0.02 Q1 '25: -0.01 Q2 '25: -0.00 Q3 '25: -0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '26: 0.00 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.